Hello, Guest!
  • Thursday, November 14, 2024

Carl Rosenblatt Named CNSI EVP, Chief Business Dev’t Officer; Todd Stottlemyer Quoted


Carl Rosenblatt

Carl Rosenblatt, formerly mid-Atlantic sales and marketing leader at PwC, has joined health information technology systems provider CNSI as an executive vice president and chief business development officer.

He will oversee CNSI™s sales and business development initiatives, the company said Wednesday.

Todd Stottlemyer, CEO of CNSI and a 2019 Wash100 winner, said Rosenblatt™s business development experience would help expand the company™s efforts to deliver novel platforms meant to reduce health care costs and improve health outcomes.

Rosenblatt brings to the newly created position nearly three decades of business development and sales experience in federal, state government and commercial markets.

He has held leadership positions at Acentia, QinetiQ North America, BearingPoint and SRA. He started his career as a sports writer for The Washington Post and has authored books about business capture and development, pricing and proposal development.

Video of the Day

Related Articles

Roundup of 2022: GovCon’s Top 22 M&A Transactions With Business Leaders’ Strategic Outlook M&A Activity

Roundup of 2022: GovCon’s Top 22 M&A Transactions With Business Leaders’ Strategic Outlook

In 2022, the GovCon landscape saw announcements and completions of merger-and-acquisition deals at privately held, publicly traded and private equity backed companies that sought to expand what they could offer to their federal customers. Continuing reading below for Executive Mosaic editorial team’s rundown of transactions and insights from industry executives who helped steward the market’s

CNSI to Merge With Private Equity-Backed Kepro in Government Health Market Push M&A Activity

CNSI to Merge With Private Equity-Backed Kepro in Government Health Market Push

CNSI, a portfolio company of Carlyle (Nasdaq: CG), and health care management services provider Kepro have agreed to combine operations under a merger transaction with an undisclosed sum. Private equity firm Apax Partners will let go of its ownership stake in Kepro through the deal and CNSI said Wednesday the parties expect to complete the

CNSI Forms New Board Post-Carlyle Acquisition Executive Moves

CNSI Forms New Board Post-Carlyle Acquisition

Health information technology firm CNSI established a new board of directors composed of government technology and health care industry veterans, six months after being acquired by global investment firm Carlyle (Nasdaq: CG). CNSI CEO Todd Stottlemyer will serve as a member of the board chaired by Donna Morea, an operating executive with Carlyle since 2016